Home > Healthcare > Biotechnology > Biotechnology R&D > Non-animal Alternative Testing Market

Non-animal Alternative Testing Market Trends

  • Report ID: GMI5704
  • Published Date: May 2023
  • Report Format: PDF

Non-animal Alternative Testing market Trends

Pre-clinical studies give information on the safety and efficacy of a potential drug prior to testing it on humans. Such research involves proper preclinical models to compare it to the real-world population in order to obtain accurate results. Studies on animals are helping researchers discover regarding potential drug toxicity and dosing. As a result, the demand for drug research and development grows as well as the demand for animal models also increases, thereby fostering the market trends.

Further, PETA and Cruelty-Free International agencies are pressurising on the end-user industry to switch animal models to the alternate methods that ensure no animals are harmed, abused, or used in any way that affects the animal as well as people's sentiments. Hence, the awareness pertaining to non-animal alternative testing will propel the market outlook.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for non-animal alternative testing was valued at USD 1,725.0 million in 2022 and is expected to surpass USD 4,534.2 million by 2032 at 10.3% CAGR attributed to the rising emphasis on animal welfare.

The cell culture technology segment generated USD 746.9 million in 2022 and is anticipated to grow at a steady pace through 2032 owing to its extensive use by researchers for analyzing many test results simultaneously.

The North America non-animal alternative testing market amassed USD 653.8 million in 2022 and is poised to grow at 8.2% CAGR through 2032 due to the presence of key players in the region.

AlveoliX AG, MIMETAS, MatTek Corporation, Emulate, Inc, VITROCELL Systems GmbH, Bio-Rad Laboratories, Inc., Hurel Corporation, Evotec SE, MB Research Laboratories, and TissUse GmbH are the prominent companies in the market.

Non-animal Alternative Testing Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 342
  • Countries covered: 20
  • Pages: 180
 Download Free Sample